Tanne D - Search Results

1

Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group.

Tanne D, Bates VE, Verro P, Kasner SE, Binder JR, Patel SC, Mansbach HH, Daley S, Schultz LR, Karanjia PN, Scott P, Dayno JM, Vereczkey-Porter K, Benesch C, Book D, Coplin WM, Dulli D, Levine SR. Tanne D, et al. Neurology. 1999 Jul 22;53(2):424-7. doi: 10.1212/wnl.53.2.424. Neurology. 1999. PMID: 10430444 Clinical Trial.

2

Safer thrombolysis for acute ischemic stroke: is early recanalization the key?

Tanne D, Levine SR. Tanne D, et al. Neurology. 2008 Oct 21;71(17):1300-1. doi: 10.1212/01.wnl.0000327700.34223.8e. Neurology. 2008. PMID: 18936422 No abstract available.

3

Anticardiolipin antibodies and their associations with cerebrovascular risk factors.

Tanne D, D'Olhaberriague L, Schultz LR, Salowich-Palm L, Sawaya KL, Levine SR. Tanne D, et al. Among authors: d olhaberriague l. Neurology. 1999 Apr 22;52(7):1368-73. doi: 10.1212/wnl.52.7.1368. Neurology. 1999. PMID: 10227619

4

Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience.

Tanne D, Gorman MJ, Bates VE, Kasner SE, Scott P, Verro P, Binder JR, Dayno JM, Schultz LR, Levine SR. Tanne D, et al. Stroke. 2000 Feb;31(2):370-5. doi: 10.1161/01.str.31.2.370. Stroke. 2000. PMID: 10657408

5

Predictors of good outcome after intravenous tPA for acute ischemic stroke.

Demchuk AM, Tanne D, Hill MD, Kasner SE, Hanson S, Grond M, Levine SR; mMulticentre tPA Stroke Survey Group. Demchuk AM, et al. Among authors: tanne d. Neurology. 2001 Aug 14;57(3):474-80. doi: 10.1212/wnl.57.3.474. Neurology. 2001. PMID: 11502916

6

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.

Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine SR. Tanne D, et al. Circulation. 2002 Apr 9;105(14):1679-85. doi: 10.1161/01.cir.0000012747.53592.6a. Circulation. 2002. PMID: 11940547

7

Prediction of hospital disposition after thrombolysis for acute ischemic stroke using the National Institutes of Health Stroke Scale.

Schlegel DJ, Tanne D, Demchuk AM, Levine SR, Kasner SE; Multicenter rt-PA Stroke Survey Group. Schlegel DJ, et al. Among authors: tanne d. Arch Neurol. 2004 Jul;61(7):1061-4. doi: 10.1001/archneur.61.7.1061. Arch Neurol. 2004. PMID: 15262736

8

A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke.

Cucchiara B, Tanne D, Levine SR, Demchuk AM, Kasner S. Cucchiara B, et al. Among authors: tanne d. J Stroke Cerebrovasc Dis. 2008 Nov-Dec;17(6):331-3. doi: 10.1016/j.jstrokecerebrovasdis.2008.03.012. J Stroke Cerebrovasc Dis. 2008. PMID: 18984422

9

Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases.

D'Olhaberriague L, Levine SR, Salowich-Palm L, Tanne D, Sawaya KL, Aurora TK, Perry M, Day M, Spencer T, Schultz L. D'Olhaberriague L, et al. Among authors: tanne d. Neurology. 1998 Nov;51(5):1376-80. doi: 10.1212/wnl.51.5.1376. Neurology. 1998. PMID: 9818863

10

Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA Stroke Trial.

Tanne D, Levine SR, Brey RL, Lin H, Tilley BC; NINDS rt-PA Stroke Study Group. Tanne D, et al. Neurology. 2003 Oct 28;61(8):1158-9. doi: 10.1212/01.wnl.0000086809.46485.a1. Neurology. 2003. PMID: 14581697 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters